EGF receptor (EGFR) inhibition promotes a slow-twitch oxidative, over a fast-twitch, muscle phenotype
- Ciano, M., Mantellato, G., Connolly, M., Paul-Clark, M., Willis-Owen, S., Moffatt, M.F., Cookson, W.O.C.M., Mitchell, J.A., Polkey, M.I., Hughes, S.M., Kemp, P.R., Natanek, S.A.
- Scientific Reports 9: 9218 (Journal)
- Registered Authors
- Hughes, Simon M.
- MeSH Terms
- Case-Control Studies
- Epidermal Growth Factor/genetics
- ErbB Receptors/antagonists & inhibitors*
- Locomotion/drug effects
- Middle Aged
- Muscle Fibers, Fast-Twitch/drug effects*
- Muscle Fibers, Fast-Twitch/metabolism*
- Muscle Fibers, Fast-Twitch/physiology
- Muscle Fibers, Slow-Twitch/drug effects*
- Muscle Fibers, Slow-Twitch/metabolism*
- Muscle Fibers, Slow-Twitch/physiology
- Oxidation-Reduction/drug effects
- Protein Kinase Inhibitors/pharmacology*
- Pulmonary Disease, Chronic Obstructive/genetics
- Pulmonary Disease, Chronic Obstructive/physiopathology
- RNA, Messenger/genetics
- 31239465 Full text @ Sci. Rep.
Ciano, M., Mantellato, G., Connolly, M., Paul-Clark, M., Willis-Owen, S., Moffatt, M.F., Cookson, W.O.C.M., Mitchell, J.A., Polkey, M.I., Hughes, S.M., Kemp, P.R., Natanek, S.A. (2019) EGF receptor (EGFR) inhibition promotes a slow-twitch oxidative, over a fast-twitch, muscle phenotype. Scientific Reports. 9:9218.
A low quadriceps slow-twitch (ST), oxidative (relative to fast-twitch) fiber proportion is prevalent in chronic diseases such Chronic Obstructive Pulmonary Disease (COPD) and is associated with exercise limitation and poor outcomes. Benefits of an increased ST fiber proportion are demonstrated in genetically modified animals. Pathway analysis of published data of differentially expressed genes in mouse ST and FT fibers, mining of our microarray data and a qPCR analysis of quadriceps specimens from COPD patients and controls were performed. ST markers were quantified in C2C12 myotubes with EGF-neutralizing antibody, EGFR inhibitor or an EGFR-silencing RNA added. A zebrafish egfra mutant was generated by genome editing and ST fibers counted. EGF signaling was (negatively) associated with the ST muscle phenotype in mice and humans, and muscle EGF transcript levels were raised in COPD. In C2C12 myotubes, EGFR inhibition/silencing increased ST, including mitochondrial, markers. In zebrafish, egfra depletion increased ST fibers and mitochondrial content. EGF is negatively associated with ST muscle phenotype in mice, healthy humans and COPD patients. EGFR blockade promotes the ST phenotype in myotubes and zebrafish embryos. EGF signaling suppresses the ST phenotype, therefore EGFR inhibitors may be potential treatments for COPD-related muscle ST fiber loss.
Genes / Markers
Mutation and Transgenics
Human Disease / Model Data
Sequence Targeting Reagents
Engineered Foreign Genes
Errata and Notes